lisdexamfetamin al 40 mg hartkapseln
aliud pharma gmbh (3270510) - hartkapsel - 40 mg
elvanse 20 mg hartkapsel
shire pharmaceuticals ireland - lisdexamfetamine dimesylate - hartkapsel - 20 mg - lisdexamfetamine dimesylate 20 mg - lisdexamfetamine
elvanse 30 mg hartkapsel
shire pharmaceuticals ireland - lisdexamfetamine dimesylate - hartkapsel - 30 mg - lisdexamfetamine dimesylate 30 mg - lisdexamfetamine
elvanse 40 mg hartkapsel
shire pharmaceuticals ireland - lisdexamfetamine dimesylate - hartkapsel - 40 mg - lisdexamfetamine dimesylate 40 mg - lisdexamfetamine
elvanse 50 mg hartkapsel
shire pharmaceuticals ireland - lisdexamfetamine dimesylate - hartkapsel - 50 mg - lisdexamfetamine dimesylate 50 mg - lisdexamfetamine
elvanse 60 mg hartkapsel
shire pharmaceuticals ireland - lisdexamfetamine dimesylate - hartkapsel - 60 mg - lisdexamfetamine dimesylate 60 mg - lisdexamfetamine
elvanse 70 mg hartkapsel
shire pharmaceuticals ireland - lisdexamfetamine dimesylate - hartkapsel - 70 mg - lisdexamfetamine dimesylate 70 mg - lisdexamfetamine
intuniv
takeda pharmaceuticals international ag ireland branch - guanfacinhydrochlorid - aufmerksamkeitsdefizitsyndrom mit hyperaktivität - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv verwendet werden muss, als teil einer umfassenden adhs-behandlung programm, in der regel einschließlich der psychologischen, pädagogischen und sozialen maßnahmen.
intuniv 1 mg retardtabletten
takeda pharma ag - guanfacinum - retardtabletten - guanfacinum 1 mg ut guanfacini hydrochloridum, hypromellosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.03570261 mg, polysorbatum 80, cellulosum microcristallinum, silica colloidalis anhydrica, lactosum monohydricum 23.59 mg, povidonum k 30, crospovidonum, glyceroli dibehenas, acidum fumaricum, pro compresso. - adhs bei kindern und jugendlichen (6-17 jahre) - synthetika
intuniv 2 mg retardtabletten
takeda pharma ag - guanfacinum - retardtabletten - guanfacinum 2 mg ut guanfacini hydrochloridum, hypromellosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.071402 mg, polysorbatum 80, cellulosum microcristallinum, silica colloidalis anhydrica, lactosum monohydricum 47.18 mg, povidonum k 30, crospovidonum, glyceroli dibehenas, acidum fumaricum, pro compresso. - adhs bei kindern und jugendlichen (6-17 jahre) - synthetika